J Am Dent Assoc. 2017 Oct;148(10):743-749.e9. doi: 10.1016/j.adaj.2017.05.007. Epub 2017 Jul 13.
The relationship between levels of salivary and serum interleukin (IL)-6 and oral lichen planus (OLP) is not understood fully. The authors conducted a systematic review and meta-analysis to compare levels of salivary and serum IL-6 among people with OLP and healthy control participants.
The authors searched the literature for studies whose investigators had evaluated the relationships between IL-6 and OLP before treatment. The authors used meta-analysis to compare the standardized mean differences (SMD) of the levels of salivary and serum IL-6 between people who had OLP and people who did not have OLP and between patients with erosive OLP and patients with nonerosive OLP.
The results of separate meta-analyses, which included 5 studies each, indicated that the levels of salivary and serum IL-6 were significantly higher among patients with OLP than among healthy control participants (SMD, 2.35; 95% confidence interval [CI], 0.50 to 4.19; P = .01; and SMD, 2.03; 95% CI, 0.74 to 3.33; P = .002; respectively). The results of a meta-analysis of 4 studies indicated that the levels of IL-6 were not significantly different between patients with erosive OLP and patients with nonerosive OLP (SMD, 1.37; 95% CI, -0.26 to 3.00; P = .10). There was significant heterogeneity among the studies (P < .00001).
Through the results of this meta-analysis, the authors found significant differences in the levels of IL-6 in saliva and serum between patients with OLP and healthy control participants. The authors found no differences in the levels of serum IL-6 between patients with erosive OLP and patients with nonerosive OLP. These results should be considered with caution because there was a high degree of heterogeneity among studies.
Levels of IL-6 in saliva and serum may be potential biomarkers for OLP. However, additional research is needed to confirm findings of this meta-analysis.
唾液和血清白细胞介素 (IL)-6 水平与口腔扁平苔藓 (OLP) 之间的关系尚未完全阐明。作者进行了系统评价和荟萃分析,以比较 OLP 患者和健康对照者的唾液和血清 IL-6 水平。
作者检索了评估治疗前 IL-6 与 OLP 之间关系的研究。作者使用荟萃分析比较了 OLP 患者与无 OLP 患者以及糜烂性 OLP 患者与非糜烂性 OLP 患者的唾液和血清 IL-6 水平的标准化均数差 (SMD)。
单独进行的荟萃分析(每项分析包括 5 项研究)的结果表明,OLP 患者的唾液和血清 IL-6 水平明显高于健康对照组(SMD,2.35;95%置信区间 [CI],0.50 至 4.19;P=0.01;SMD,2.03;95%CI,0.74 至 3.33;P=0.002)。对 4 项研究进行的荟萃分析结果表明,糜烂性 OLP 患者与非糜烂性 OLP 患者的 IL-6 水平无显著差异(SMD,1.37;95%CI,-0.26 至 3.00;P=0.10)。研究之间存在显著异质性(P<0.00001)。
通过这项荟萃分析的结果,作者发现 OLP 患者的唾液和血清中 IL-6 水平存在显著差异。作者发现糜烂性 OLP 患者与非糜烂性 OLP 患者的血清 IL-6 水平无差异。这些结果应谨慎考虑,因为研究之间存在高度异质性。
唾液和血清中的 IL-6 水平可能是 OLP 的潜在生物标志物。但是,需要进一步的研究来证实这项荟萃分析的结果。